Achieve Life Sciences Appoints New CMO, Director
Ticker: ACHV · Form: 8-K · Filed: Aug 26, 2024 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.001, $615,000, $495,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment, executive-appointment
TL;DR
Achieve Life Sciences beefs up its leadership team with a new CMO and a board member.
AI Summary
Achieve Life Sciences, Inc. announced on August 20, 2024, the appointment of Dr. Cherise Smith as Chief Medical Officer and the election of Ms. Jennifer Cook to its Board of Directors. The company also disclosed compensatory arrangements for its officers. This filing follows a period of corporate name changes, previously being OncoGenex Pharmaceuticals, Inc. and Sonus Pharmaceuticals Inc.
Why It Matters
Key leadership changes and board appointments can signal strategic shifts or new directions for a life sciences company, potentially impacting its research and development pipeline.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and execution, especially in the volatile life sciences sector.
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- Dr. Cherise Smith (person) — Appointed Chief Medical Officer
- Ms. Jennifer Cook (person) — Elected to Board of Directors
- OncoGenex Pharmaceuticals, Inc. (company) — Former Company Name
- Sonus Pharmaceuticals Inc (company) — Former Company Name
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Cherise Smith has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors?
Ms. Jennifer Cook has been elected to the Board of Directors.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated August 20, 2024.
What were the previous names of Achieve Life Sciences, Inc.?
Achieve Life Sciences, Inc. was formerly known as OncoGenex Pharmaceuticals, Inc. and Sonus Pharmaceuticals Inc.
What is the company's Standard Industrial Classification code?
The company's Standard Industrial Classification code is 2835, for In Vitro & In Vivo Diagnostic Substances.
Filing Stats: 2,214 words · 9 min read · ~7 pages · Grade level 10.6 · Accepted 2024-08-26 16:39:30
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ACHV The NASDAQ Stock Mar
- $615,000 — ve (i) an initial annual base salary of $615,000 per year (the " Stewart Base Salary "),
- $495,000 — s: (i) an initial annual base salary of $495,000 per year (the " King Base Salary "), (i
Filing Documents
- d834963d8k.htm (8-K) — 41KB
- 0001193125-24-207129.txt ( ) — 197KB
- achv-20240820.xsd (EX-101.SCH) — 3KB
- achv-20240820_def.xml (EX-101.DEF) — 13KB
- achv-20240820_lab.xml (EX-101.LAB) — 22KB
- achv-20240820_pre.xml (EX-101.PRE) — 14KB
- d834963d8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACHIEVE LIFE SCIENCES, INC. Date: August 26, 2024 /s/ Richard Stewart Richard Stewart Chief Executive Officer (Principal Executive and Financial Officer)